Dr. (Andrew) Dror Rosenbach, MD — board-certified psychiatrist offering Ketamine-Assisted Psychotherapy (KAP) in Tel Aviv, Israel. Structured, medically supervised treatment for depression, PTSD, trauma, and treatment-resistant conditions. In-home ketamine sessions available. English and Hebrew speaking patients welcome.
This brief screening call helps determine whether ketamine-assisted psychotherapy may be appropriate for your situation. It is not a full psychiatric evaluation, but a first step to assess clinical fit and next steps. The call is complimentary, takes 10–15 minutes, and can be conducted by phone or video.
Ketamine-Assisted Psychotherapy (KAP) is a structured, psychiatrist-led treatment that combines intramuscular ketamine with psychotherapy. It is designed for individuals who have not found sufficient relief from standard antidepressants or psychotherapy alone. All sessions are conducted in the patient's home in the Tel Aviv area under full medical supervision. This is not a wellness service — it is a prescription medical treatment requiring full psychiatric evaluation and informed consent.
Important: This service is structured and medically supervised. Not all individuals are appropriate candidates. Treatment candidacy is determined through a formal psychiatric evaluation. Ages 18+ only. Located in Tel Aviv, Israel.
Dr. (Andrew) Dror Rosenbach is a U.S. board-certified psychiatrist and Israel-licensed specialist with over 20 years of clinical experience. He offers Ketamine-Assisted Psychotherapy (KAP) in Tel Aviv for adults with treatment-resistant depression, PTSD, and complex trauma. Sessions are conducted in-home in the Tel Aviv area. English and Hebrew spoken.
All services are private pay. Detailed itemized receipts are provided for insurance reimbursement.
KAP combines ketamine administration with structured psychotherapy. The medicine creates a temporary altered state that can help dissolve rigid thought patterns and reduce depression. Dr. Rosenbach integrates it with preparation and integration sessions for lasting benefit.
Good candidates have tried conventional treatments without sufficient relief, do not have contraindications (uncontrolled psychosis, active mania), and are open to a structured therapeutic process. Full candidacy is determined through a psychiatric evaluation.
Ketamine has been used safely as an anesthetic for over 50 years. At therapeutic doses with physician supervision, serious adverse events are rare. Dr. Rosenbach conducts thorough screening before treatment begins.
All new patients begin through a structured, secure clinical intake process. A free 15–20 minute screening call is available before committing to a full evaluation.